Intrexon Corporation’s Oxitec Ltd. said Thursday that the municipality of Piracicaba, Brazil saw a 52% reduction in dengue fever cases this year after the company’s genetically-engineered mosquitoes were released. The effect, which compared the number of cases with those the previous year, amounted to a 91% drop in the municipality’s 5,000 resident CECAP/Eldorado district, which typically sees much higher rates of dengue than the rest of Piracicaba, the company said. The data was courtesy of Piracicaba’s Epidemiologic Surveillance service. Oxitec has also proposed to release genetically-engineered mosquitoes in the Florida Keys, where the plan has met with local opposition.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News